GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Beijing Tiantan Biological Products Corp 600161.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

12.51

-1.26%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

8 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 2Strong buy
  • 4Buy
  • 2Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Average target 24.62

Low
22.83
Average
24.62
Median
24.48
High
27.11

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueCN¥5.91bnCN¥6.57bnCN¥7.57bn
Revenue, highestCN¥6.52bnCN¥7.46bnCN¥8.52bn
Revenue, lowestCN¥5.19bnCN¥5.48bnCN¥6.47bn
Earnings per share0.470.540.72
Earnings per share, highest0.490.550.97
Earnings per share, lowest0.440.530.58
Analysts343

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Forecast0.150.090.060.170.200.180.150.14
Reported0.070.140.060.090.200.120.250.16
Difference-53.4%+54.3%0.0%-46.0%-1.7%-31.7%+62.9%+18.5%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

7 / 10

Revenue growth 14.3% a year over 10 years. Return on equity 9.3%.

Model fair value

14.83

From earnings 14.83, from revenue 19.04.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.